Grape Seed Extract, graded Moderate-evidence on Magellan — meta-analyses show modest blood-pressure reductions (~2–6 mmHg systolic), largest in younger or metabolically impaired people; effects on lipids and glycemia are small and inconsistent. New fatty-liver benefits rest on two small single-country trials, one trial found no cognitive benefit, and no hard cardiovascular outcomes have been tested.
Source: Nutrients 2021, PMID 33671310 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: high
Grape seed extract (GSE) is a polyphenol-rich preparation made from the seeds of wine grapes (Vitis vinifera), standardized primarily for proanthocyanidins (oligomeric procyanidins) along with catechins and other flavonoids. Marketed as a dietary supplement, it has antioxidant and anti-inflammatory activity. Preclinical work indicates that its proanthocyanidins can increase endothelial nitric oxide synthase (eNOS) expression and nitric oxide production, in part through AMPK/SIRT1/KLF2 signaling, and can lower endothelin-1 and oxidative stress, which together support endothelial function and vascular tone.
Randomized trials and meta-analyses indicate that grape seed extract can modestly lower blood pressure — pooled systolic reductions of roughly 2–6 mmHg, larger in younger, obese, or metabolic-syndrome patients — and may improve markers of blood glucose, LDL cholesterol, triglycerides, and inflammation. Two small 2024 trials in non-alcoholic fatty liver disease reported improved insulin resistance, liver enzymes, oxidative stress, and quality of life, though both were single-center studies of about 50 people. Effects on flow-mediated dilation are inconsistent, with some trials and one large meta-analysis showing no significant change, and a 12-week trial in healthy young adults found no cognitive benefit. The literature is limited by small, heterogeneous, often short and sometimes industry-funded studies, and there is no evidence on lifespan or hard cardiovascular outcomes. This evidence characterizes the grape seed extract compound and its active proanthocyanidins in general, not this specific commercial product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“both supplementations significantly modulated blood pressure”
“mean SBP in the high-dose group significantly decreased by 13 mmHg after 12 weeks”
“Overall analyses found significant reductions for SBP (WMD = -6.077; 95% CI: -10.736 to -1.419; P = 0.011) and DBP (WMD = -2.803; 95% CI: -4.417 to -1.189; P = 0.001) after grape seed extract treatment.”
“Based on the currently available literature, grape seed extract appears to significantly lower systolic blood pressure and heart rate, with no effect on lipid or CRP levels.”
“In conclusion, GSE may be beneficial for individuals with or at risk of cardiovascular disease because it may have hypotensive and HR-lowering properties.”
“This meta-analysis demonstrated that GSE intake significantly reduced FPG, TC, LDL cholesterol, triglycerides, and CRP levels.”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 21 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.